Eli Lilly and Company (LLY)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	2,920,000	933,700	234,000	-629,900	-1,337,200	-1,535,600	-282,100	-575,400	564,300	647,900	1,187,200	881,300	-483,600	139,600	-688,500	-476,400	-138,600	1,226,100	1,652,600	1,613,500
Total assets	US$ in thousands	78,714,900	75,606,900	71,874,800	63,943,500	64,006,300	57,915,500	54,814,000	53,163,000	49,489,800	47,461,500	47,063,600	46,919,300	48,806,000	48,187,000	47,809,000	46,838,300	46,633,100	43,946,000	41,967,000	41,102,800
Operating ROA		3.71%	1.23%	0.33%	-0.99%	-2.09%	-2.65%	-0.51%	-1.08%	1.14%	1.37%	2.52%	1.88%	-0.99%	0.29%	-1.44%	-1.02%	-0.30%	2.79%	3.94%	3.93%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $2,920,000K ÷ $78,714,900K
= 3.71%

The operating return on assets (operating ROA) of Eli Lilly and Company has fluctuated over the periods provided. The performance ranged from negative percentages to positive percentages, indicating variability in efficiency in generating profits from its assets. Notably, there were quarters with negative operating ROA, suggesting that the company struggled in utilizing its assets effectively to generate operating profits during those periods. However, there were also quarters where the operating ROA showed improvements, with percentages reaching positive values, reflecting better asset utilization and operational performance. Overall, the trend in operating ROA for Eli Lilly and Company shows a mix of challenges and strengths in effectively leveraging its assets to generate operating income.